All News

03:02pm Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says RE
12:38pm Merck Announces FDA Grants Priority Review For Keytruda And Keytruda Qlex Each With Padcev For Cisplatin-Eligible Patients With Muscle-Invasive Bladder Cancer CI
12:24pm Pfizer's Upcoming Tafamidis Bench Trial Shows Asymmetric Upside, RBC Capital Markets Says MT
09:50am Astellas Pharma Inc. And Pfizer Inc. Receive U.S. FDA Priority Review For PADCEV And Keytruda As Perioperative Treatment For Muscle-Invasive Bladder Cancer CI
07:45am Merck, Pfizer, Astellas Drug Combo Gets Speedy FDA Review in Bladder Cancer DJ
07:43am Merck Says FDA Grants Priority Review to Keytruda-Padcev Combo for Bladder Cancer MT
06:46am U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility PR
05:24am Pfizer, Amgen Eyeing Hong Kong Expansion MT
Apr. 16 CICC Initiates Pfizer at Outperform With $33 Price Target MT
Apr. 16 Harbour Biomed Appoints Adam Zong as President CI
Apr. 15 DND Pharmatech Wins KRW1.83 Billion Anti-Obesity Drug Formulation Contract from Pfizer; Shares Rise 3% MT
Apr. 14 Structure Therapeutics Names Matthew Lang as COO MT
Apr. 14 Pharma sector doubles down on AI amid hopes of slashing costs, timelines RE
Apr. 13 Lineage Cell Therapeutics, Inc. Announces Formation of Scientific Advisory Board and Executive Appointment CI
Apr. 13 UBS Raises Price Target on Pfizer to $27 From $25, Maintains Neutral Rating MT
Apr. 13 Orum Therapeutics, Inc. Appoints Maria Koehler and Geoff Meyerson to Board of Directors CI
Apr. 13 Earnings Season in Trump's Shadow Zonebourse
Apr. 13 Pfizer Renews Licensing Deal With Trellus Health for Patient Support Educational Content MT
Apr. 13 Shares fall as oil climbs back above USD100 AN
Apr. 13 WINNERS & LOSERS: Energy stocks up; Wise gains on growth update AN
Apr. 13 Trellus Health signs renewal of licensing deal with Pfizer AN
Apr. 13 BMO Capital Adjusts Price Target on Pfizer to $34 From $30, Maintains Outperform Rating MT
Apr. 13 IDEAYA and Servier's eye cancer drug meets trial goal, paving way for FDA application RE
Apr. 13 Trellus Health Plc Signs Licensing Agreement Renewal With Pfizer Inc CI
Apr. 13 Trellus Health, Pfizer Renew Patient Support Content License Deal MT
No results for this search